Skip to main content
Clinical Trials/DRKS00028152
DRKS00028152
Completed
Phase 4

Outpatient remobilization after total knee and hip arthroplasties - AMB-REMOB

udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research0 sites100 target enrollmentMarch 15, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
M16.1
Sponsor
udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 15, 2022
End Date
April 28, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
udwig Boltzmann Gesellschaft, Ludwig Boltzmann Institute for Rehabilitation Research

Eligibility Criteria

Inclusion Criteria

  • Planned unilateral knee or hip replacement for gonarthrosis.
  • Relatively painless and symptom\-free contralateral lower extremity (no effusion, no load\-limiting pain, VAS less than 5\)
  • Age between 55 and 80 years
  • Good general health with good exercise capacity (defined by exclusion criteria)
  • Inclusion of men and non\-childbearing women (postmenopausal and other reasons, to be confirmed by pregnancy test in case of doubt)

Exclusion Criteria

  • Previous knee or hip arthroplasty
  • Body mass index (BMI) greater than 40
  • Any conditions/states according to fresh leg vein thrombosis (shorter than 3 weeks),
  • Higher degree of joint effusion
  • infection
  • Pre\-existing myopathy
  • Relevant neurological diseases with gait disturbance (Polyneuropathies, MB, Parkinson's)
  • Dementia / reduced cognitive abilities
  • Vestibular diseases with vertigo or balance disorders
  • Symptomatic cardiopulmonary disease in the past 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials